Providing the most up-to-date, complete and innovative injectable drug compatibility and stability information in hospital pharmacy worldwide, the King Guide is a proven, authoritative resource for pharmacists, nurses, physicians and other practitioners involved in the preparation and administration of intravenous drugs.
"This is the most updated information on parenteral admixtures on the market."
IJPC Vol.5 No.4 July/August 2001.
Features
In this Supplement we added new monographs for CIFIDEROCOL SULFATE TOSYLATE, ISATUXIMAB, and SMOFLIPID.
We also added new stability information to these existing drug monographs: ACYCLOVIR SODIUM, AMIODARONE HYDROCHLORIDE, AMOXACILLIN SODIUM, AMPICILLIN SODIUM, AZTREONAM, BORTEZOMIB, BUSULFAN, CEFEPIME HYDROCHLORIDE, CEFTRIAXONE SODIUM, CIPROFLOXACIN, CISATRACURIUM BESYLATE, CYTARABINE, GENTAMICIN SULFATE, HEPARIN SODIUM, HYDROCORTISONE SODIUM SUCCINATE, KETAMINE HYDROCHLORIDE, LEVOFLOXACIN, MEROPENEM, MORPHINE SULFATE, TOBRAMYCIN SULFATE, and VANCOMYCIN HYDROCHLORIDE.
New compatibility information was added to these existing drug monographs: ACETAMINOPHEN, ALBUMIN, HUMAN SERUM, BUSULFAN, CEFEPIME HYDROCHLORIDE, CEFTOLOZANE AND TAZOBACTAM, CIPROFLOXACIN, CISATRACURIUM BESYLATE, DORIPENEM, EPINEPHRINE HYDROCHLORIDE, ESOMEPRAZOLE SODIUM, FLUDARABINE PHOSPHATE, HYDROCORTISONE SODIUM SUCCINATE, IBUPROFEN, LEVOFLOXACIN, LEVOTHYROXINE SODIUM, MEROPENEM, and NOREPINEPHRINE BITARTRATE.